CSIMarket Company Name, Ticker, Suppliers, else..
 
Intelligent Bio Solutions Inc   (NASDAQ: INBS)
 
Price: $2.2300 $-0.07 -3.043%
Day's High: $2.4000000953674316 Week Perf: -7.08 %
Day's Low: $ 2.15 30 Day Perf: 12.06 %
Volume (M): 91,700 52 Wk High: $ 24.90
Volume (M$): $ 0 52 Wk Avg: $5.81
Open: $2.29 52 Wk Low: $1.52



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 1
 Employees 13
 Revenues (TTM) (Millions $) 4
 Net Income (TTM) (Millions $) -12
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) 0

Business Description


Intelligent Bio Solutions Inc is a company that specializes in developing intelligent solutions for the biological sciences field. They focus on creating innovative technologies and software to enhance research and analysis processes in various areas such as genomics, proteomics, and bioinformatics. Their products aim to improve efficiency, accuracy, and productivity in scientific research, aiding researchers in their quest to understand biological systems and develop new treatments and therapies. The company is committed to staying at the forefront of technological advancements and partnering with academic institutions and organizations to drive advancements in the biological sciences.


   Company Address: 135 West 41st Street New York 10036 NY
   Company Phone Number: 828-8258   Stock Exchange / Ticker: NASDAQ INBS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BJDX   -7.56%    
MDT        3.22% 
OSUR   -3.33%    
QDEL   -5.22%    
• View Complete Report
   



Contract

Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider

Published Thu, Oct 23 2025 4:07 PM UTC

Breaking New Ground: Intelligent Bio Solutions Gains Major Partnerships with Industry GiantsIntelligent Bio Solutions has recently secured a significant contract with a multinational industrial service provider in the UK, marking a pivotal moment for the company as it continues to expand its reach in Europe. The industrial giant, employing approximately 3,000 staff within t...
Shares

Bio Solutions Inc. Secures $3 Million in Public Offering Boosting Market Confidence

Published Fri, Feb 21 2025 9:05 PM UTC

In the ever-evolving world of medical technology, Intelligent Bio Solutions Inc. (Nasdaq: INBS) has taken a strategic step forward by successfully concluding its $3.0 million public offering of common stock. The New York-based company, known for its innovative, rapid, and non-invasive testing solutions, announced the closing of this financial milestone on February 21, 2025. ...
Shares

Bio Solutions New Public Offering: A Step Towards Growth Amidst Stock Restructuring

Published Wed, Feb 19 2025 9:42 PM UTC

In a press release dated February 19, 2025, Intelligent Bio Solutions Inc. (Nasdaq: INBS) announced its intention to commence an underwritten public offering of shares of its common stock. As a leading entity in the medical technology sphere, the company specializes in rapid, non-invasive testing solutions. However, the press release indicated that the offering s completion,...
Product Service News

Breaking Barriers How Bio Solutions is Transforming Global Drug Screening through Multilingual Innovation,

Published Fri, Jan 31 2025 6:19 PM UTC

Intelligent Bio Solutions: Pioneering a Global Approach to Drug Screening In an era marked by rapid technological advancements and an increasingly interconnected world, Intelligent Bio Solutions Inc (INBS) is at the forefront of a movement that seeks to transcend linguistic barriers. Through its revolutionary upgrade, the INBS Drug Screening System is set to become a truly g...
Clinical Study

Pioneering Precision Bio Solutions Makes Strides in Drug Screening Accuracy and FDA Submission Readiness

Published Tue, Nov 26 2024 1:30 PM UTC

In an era where technological innovation intersects with healthcare, Intelligent Bio Solutions (IBS) has made significant waves in the field of drug screening. Recently, the company achieved a remarkable 94.1% accuracy in its method comparison study, coinciding with favorable pharmacokinetic (PK) study results. Furthermore, the Intelligent Fingerprinting Drug Screening Syste...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.78
Price to Sales (Expected) -
Price to Book 0.6
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.84
Working Capital Ratio 1.44
Leverage Ratio (MRQ) 1.17
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -10.77 $
Revenues (TTM) 2.86 $
Cash Flow (TTM) 3.97 $
Cash 2.81 $
Book Value 3.74 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 324,244
Net Income per Employee (TTM) -959,129
Receivable Turnover Ratio (TTM) 5.55
Inventory Turnover Ratio (TTM) 3.8
Asset Turnover Ratio (TTM) 0.37

Profitability Ratios Current
Gross Margin (MRQ) 46.83 %
Operating Margin (MRQ) -351.34 %
Net Margin (MRQ) -341.89 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Intelligent Bio Solutions Inc's Segments
Sales of Goods Cartidges    216.93 % of total Revenue
UNITED KINGDOM    72.16 % of total Revenue
GB    362.48 % of total Revenue
Other Country    3.49 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.